Hong Qian

Hong Qian

Auto-generated profile, based on publicly available information

Hong Qian

Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Annals of Palliative Medicine
Verified
Journal Article
Open access
PDF file
JCJing Chen
Jing Chen
XWXuesong Wang
Xuesong Wang
HQHong Qian
Hong Qian
JYJunxing Ye
Junxing Ye
JQJuan Qian
Juan Qian
JHJiao Hua
Jiao Hua
Background: Reduced postoperative mobility predisposes older patients with hip fractures to a variety of complications, including acute cerebral infarction, pressure injury, deep vein thrombosis of the lower limbs, and lung and urinary tract infections caused by prolonged bed rest. This study was designed to explore the relationship between common postoperative complications of prolonged bed rest and quality of life in hospitalized elderly hip fracture patients, in an attempt to inform the development of relevant interventions. Methods: A total of 502 patients aged 65 years or above who underwent hip fracture surgery in our center were enrolled in this study. The patients’ basic information and details of complications during their hospitalization was obtained from the case report form. The patients received telephone follow-up after discharge, and their quality of life (QoL) was measured by using the European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L). Results: During hospitalization, 98 patients (19.52%) experienced at least 1 common complication including acute cerebral infarction (n=15, 2.99%), pressure injury (n=25, 4.98%), deep vein thrombosis of the lower limbs (n=14, 2.79%), pulmonary infections (n=84, 16.73%), and urinary tract infections (n=30, 5.98%). The proportion of patients who reported problems including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression was higher in those who experienced complications. Conclusions: Active prevention of common complications caused by prolonged bed rest can improve the QoL and reduce the disease burden for elderly patients with hip fractures.

1 July 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HYHuilin Yang
Huilin Yang
HQHong Qian
Hong Qian
BLBo Liu
Bo Liu
Yanqi WuYanqi Wu
Yanqi Wu
YCYumei Cheng
Yumei Cheng
FSFeng Shen
Feng Shen
Alveolar hypercoagulation and fibrinolysis inhibition were associated with the refractory hypoxemia and the high mortality in patient with acute respiratory distress syndrome (ARDS), and NF-κB pathway was confirmed to contribute to the process. Triptolide (TP) significantly inhibited NF-κB pathway and thus depressed accessive inflammatory response in ARDS. We speculate that TP could improve alveolar hypercoagulation and fibrinolytic inhibition in LPS-induced ARDS via NF-κB inactivation. The aim of this experiment was to explore the efficacy and potential mechanism of TP on alveolar hypercoagulation and fibrinolysis inhibition in LPS-induced ARDS in mice. 50 μl of LPS (5 mg/ml) was inhalationally given to C57BL/6 mice to set up ARDS model. Male mice were randomly accepted with LPS, LPS + TP (1 μg/kg, 10 μg/kg, 50 μg/kg respectively), or with NEMO Binding domain peptide (NBD), an inhibitor of NF-κB. TP (1 μg/kg, 10 μg/kg, 50 μg/kg) were intraperitoneally injected or 10 μg/50 μl of NBD solution were inhaled 30 min before LPS inhalation. A same volume of normal saline (NS) substituted for TP in mice in control. The endpoint of experiment was at 8 hours after LPS stimulation. Pulmonary tissues were taken for hematoxylin-eosin (HE) staining, wet / dry ratio and for lung injury scores (LIS). Tissue factor (TF) and plasminogen activator inhibitor (PAI)-1 in lung tissue were detected by Western-blotting and by quantitative Real-time PCR(qPCR) respectively. Concentrations of TF, PAI-1, thrombin-antithrombin complex (TAT), procollagen peptide type Ⅲ (PⅢP) and activated protein C (APC) in bronchoalveolar lavage fluid (BALF) were measured by ELISA. NF-κB activation and p65-DNA binding activity in pulmonary tissue were simultaneously determined. LPS stimulation resulted in pulmonary edema, neutrophils infiltration, obvious alveolar collapse, interstitial congestion, with high LIS, which were all dose-dependently ameliorated by Triptolide. LPS also dramatically promoted the expressions of TF and PAI-1 either in mRNA or in protein in lung tissue, and significantly stimulated the secretions of TF, PAI-1, TAT, PⅢP but inhibited APC production in BALF, which were all reversed by triptolide treatment in dose-dependent manner. TP dose-dependently inhibited the activation of NF-κB pathway induced by LPS, indicated by the changes of phosphorylations of p65 (p-p65), p-IKKα/β and p-IκBα, and weakened p65-DNA binding activity. TP and NBD had same efficacies either on alveolar hypercoagulation and fibrinolysis inhibition or on NF-κB signalling pathway in ARDS mice. TP dose-dependently improves alveolar hypercoagulation and fibrinolysis inhibition in ARDS mice through inhibiting NF-κB signaling pathway. Our data demonstrate that TP is expected to be an effective selection in ARDS.

1 November 2019 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
JKJacek Kopec
Jacek Kopec
QHQian Hong
Qian Hong
HWHubert Wong
Hubert Wong
CZCharlie J. Zhang
Charlie J. Zhang
CRCharles Ratzlaff
Charles Ratzlaff
JEJohn M. Esdaile
John M. Esdaile
Objective.: The purpose of the study was to determine the prevalence of femoroacetabular impingement syndrome (FAIS) in white adults 20 to 49 years of age.Methods.: Participants were white men and women aged 20–49 years, recruited through random digit dialing from the population of Metro Vancouver, British Columbia, Canada. Participants filled out a self-administered questionnaire and underwent a physical examination and radiographs of both hips. FAIS was defined as a combination of hip symptoms, physical signs of impingement, and radiological findings of cam or pincer morphology as recommended by the Warwick Agreement. All analyses were weighted to reflect the population from which the sample was drawn.Results.: Data were obtained for 500 participants. In the study population, 48.9% were males and the age distribution was 32.2%, 31.4%, and 36.4% in the groups 20–29, 30–39, and 40–49 years, respectively. The physical signs of impingement correlated significantly with symptoms, but there was no significant association between either symptoms or physical examination with radiographic findings. FAIS on either side was found in 3.0% (95% CI 1.5–4.5) of the population.Conclusion.: In this study, FAIS was present in 3% of whites aged 20–49 years. Further research is needed to develop consistent criteria for assessing hip symptoms, physical signs, and hip joint morphology, and to better understand the relationships between them.

27 June 2023 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
CJCarly E. Jones
Carly E. Jones
JCJolanda Cibere
Jolanda Cibere
HQHong Qian
Hong Qian
HZHonglin Zhang
Honglin Zhang
YGYimeng Guo
Yimeng Guo
DWDavid R. Wilson
David R. Wilson

1 September 2020 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
YOYongdong Ouyang
Yongdong Ouyang
HQHong Qian
Hong Qian
LYLakshmi N. Yatham
Lakshmi N. Yatham
HWHubert Wong
Hubert Wong
When the optimal treatment duration is uncertain, a randomized trial may allocate patients to receive active treatment for different durations. We use an example where patients receive treatment for 0, 24, or 52 weeks. In this trial, patients in the 24-weeks and 52-weeks arms receive the same treatment during the first 24 weeks. This overlap allows for more powerful analyses than conventional pair-wise comparisons of arms. When the outcome is the time-to-event, the power for the 0-weeks versus 24-weeks comparison can be increased by including patients in the 52-weeks arm as patients in the 24-weeks arm for the first 24 weeks and censoring at 24 weeks. Furthermore, differences observed between the 24-weeks and 52-weeks arms during the first 24 weeks can only reflect noise. Hence, the comparison of these two arms should be restricted to only patients who remain on the study at 24 weeks and include only the events after 24 weeks. Through simulation, we show that modified analyses accounting for these considerations increase study power substantially. Moreover, if patients were allocated equally to the arms, then events or discontinuations during the first 24 weeks will reduce the number of patients available for the 24-weeks versus 52-weeks comparison, and hence the power of this analysis will be lower than that for the 0-weeks versus 24-weeks comparison. We present a sample size calculation procedure for equalizing the power of these two analyses. Typically, this allocation requires much larger sample sizes in the 24-weeks and 52-weeks arms than in the 0-week arm.